LIPID AND APOLIPOPROTEIN ABNORMALITIES IN HIRSUTE WOMEN .1. THE ASSOCIATION WITH INSULIN RESISTANCE

被引:84
作者
WILD, RA [1 ]
ALAUPOVIC, P [1 ]
PARKER, IJ [1 ]
机构
[1] OKLAHOMA MED RES FDN,OKLAHOMA CITY,OK 73104
关键词
INSULIN RESISTANCE; GONADOTROPIN-RELEASING HORMONE ANALOG; HIRSUTISM; APOLIPOPROTEIN;
D O I
10.1016/S0002-9378(11)90605-X
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: We attempted to evaluate apolipoprotein lipid levels in hirsute hyperandrogenic women and to clarify the influence of insulin resistance versus endogenous sex steroids on these profiles. STUDY DESIGN: Forty-seven women seen for evaluation of hirsutism in the Reproductive Endocrine Clinic were contrasted with 15 normal women. Thirty-one patients were treated with the gonadotropin-releasing hormone analog, leuprolide acetate, 7.5 mg intramuscularly monthly for 3 months. Insulin resistance was assessed before and after GnRH analog administration. Mean concentrations were compared with the Student t test and analysis of variance. RESULTS: Hirsute women were heavier and had higher systolic and diastolic blood pressures, more menstrual irregularities (all p < 0.01), and higher waist/hip ratios (p < 0.05). They had higher triglyceride, very-low-density lipoprotein cholesterol, and apolipoprotein C-III levels and lower high-density lipoprotein cholesterol concentrations (all p < 0.01). They had lower apolipoprotein A-I/A-II ratios (p < 0.01). After administration of GnRH analog, androgen and estrogens were suppressed and insulin resistance was unaltered. Insulin correlated with apolipoprotein lipid abnormalities. CONCLUSION: Lipid and apolipoprotein abnormalities in these hirsute women seem to be associated more with insulin resistance than with endogenous androgens or estrogens.
引用
收藏
页码:1191 / 1197
页数:7
相关论文
共 22 条
[1]  
ALAUPOVIC P, 1990, KLIN WOCHENSCHR, V68, P38
[2]   COMPOSITION OF PLASMA APOA-I-CONTAINING LIPOPROTEIN PARTICLES IN CHILDREN AND ADULTS [J].
BEKAERT, ED ;
ALAUPOVIC, P ;
KNIGHTGIBSON, C ;
BLACKETT, P ;
AYRAULTJARRIER, M .
PEDIATRIC RESEARCH, 1991, 29 (03) :315-321
[3]   PREDICTION OF ANGIOGRAPHIC CHANGE IN NATIVE HUMAN CORONARY-ARTERIES AND AORTOCORONARY BYPASS GRAFTS - LIPID AND NONLIPID FACTORS [J].
BLANKENHORN, DH ;
ALAUPOVIC, P ;
WICKHAM, E ;
CHIN, HP ;
AZEN, SP .
CIRCULATION, 1990, 81 (02) :470-476
[4]   ESTIMATES OF INVIVO INSULIN ACTION IN MAN - COMPARISON OF INSULIN TOLERANCE-TESTS WITH EUGLYCEMIC AND HYPERGLYCEMIC GLUCOSE CLAMP STUDIES [J].
BONORA, E ;
MOGHETTI, P ;
ZANCANARO, C ;
CIGOLINI, M ;
QUERENA, M ;
CACCIATORI, V ;
CORGNATI, A ;
MUGGEO, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (02) :374-378
[5]   INSULIN RESISTANCE IN NON-OBESE PATIENTS WITH POLYCYSTIC OVARIAN DISEASE [J].
CHANG, RJ ;
NAKAMURA, RM ;
JUDD, HL ;
KAPLAN, SA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (02) :356-359
[6]   STEROID-SECRETION IN POLYCYSTIC OVARIAN DISEASE AFTER OVARIAN SUPPRESSION BY A LONG-ACTING GONADOTROPIN-RELEASING HORMONE AGONIST [J].
CHANG, RJ ;
LAUFER, LR ;
MELDRUM, DR ;
DEFAZIO, J ;
LU, JKH ;
VALE, WW ;
RIVIER, JE ;
JUDD, HL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 56 (05) :897-903
[7]   SUPPRESSION OF HYPERANDROGENISM DOES NOT IMPROVE PERIPHERAL OR HEPATIC INSULIN RESISTANCE IN THE POLYCYSTIC OVARY SYNDROME [J].
DUNAIF, A ;
GREEN, G ;
FUTTERWEIT, W ;
DOBRJANSKY, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (03) :699-704
[8]  
DUNAIF A, 1989, DIABETES, V53, P905
[9]   ANDROGEN-ESTROGEN METABOLISM IN WOMEN WITH UPPER BODY VERSUS LOWER BODY OBESITY [J].
KIRSCHNER, MA ;
SAMOJLIK, E ;
DREJKA, M ;
SZMAL, E ;
SCHNEIDER, G ;
ERTEL, N .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (02) :473-479
[10]  
KIRSCHNER MA, 1980, GYNECOLOGIC ENDOCRIN, P594